Eve Cariou

853 total citations
35 papers, 304 citations indexed

About

Eve Cariou is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Eve Cariou has authored 35 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 17 papers in Molecular Biology and 7 papers in Nephrology. Recurrent topics in Eve Cariou's work include Amyloidosis: Diagnosis, Treatment, Outcomes (17 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Cardiovascular Function and Risk Factors (9 papers). Eve Cariou is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (17 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Cardiovascular Function and Risk Factors (9 papers). Eve Cariou collaborates with scholars based in France, United States and Italy. Eve Cariou's co-authors include Olivier Lairez, Michel Galinier, Didier Carrié, Pauline Fournier, Yoan Lavie‐Badie, David Ribes, Magali Colombat, Antoine Huart, Pascal Cintas and Philippe Maury and has published in prestigious journals such as PLoS ONE, European Heart Journal and International Journal of Cardiology.

In The Last Decade

Eve Cariou

31 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eve Cariou France 10 194 178 82 59 37 35 304
Linda Pagura Italy 8 172 0.9× 183 1.0× 87 1.1× 78 1.3× 86 2.3× 22 337
J. Rahman United States 4 180 0.9× 94 0.5× 99 1.2× 43 0.7× 37 1.0× 9 249
Sneha Vakamudi United States 6 118 0.6× 149 0.8× 58 0.7× 38 0.6× 41 1.1× 12 235
Martin Nicol France 8 113 0.6× 123 0.7× 61 0.7× 39 0.7× 20 0.5× 24 237
Ghormallah B. Al-Zahrani United States 8 307 1.6× 220 1.2× 184 2.2× 48 0.8× 47 1.3× 9 407
Biju Paul Australia 7 190 1.0× 111 0.6× 89 1.1× 58 1.0× 36 1.0× 14 332
Philipp Daniel Gaudron Germany 9 149 0.8× 254 1.4× 81 1.0× 18 0.3× 46 1.2× 12 348
Annabelle Nguyen France 6 110 0.6× 220 1.2× 54 0.7× 25 0.4× 63 1.7× 10 311
Vasvi Singh United States 10 213 1.1× 101 0.6× 108 1.3× 39 0.7× 31 0.8× 35 332
Laura Krapf France 8 112 0.6× 331 1.9× 54 0.7× 26 0.4× 62 1.7× 13 456

Countries citing papers authored by Eve Cariou

Since Specialization
Citations

This map shows the geographic impact of Eve Cariou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eve Cariou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eve Cariou more than expected).

Fields of papers citing papers by Eve Cariou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eve Cariou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eve Cariou. The network helps show where Eve Cariou may publish in the future.

Co-authorship network of co-authors of Eve Cariou

This figure shows the co-authorship network connecting the top 25 collaborators of Eve Cariou. A scholar is included among the top collaborators of Eve Cariou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eve Cariou. Eve Cariou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maury, Philippe, Eve Cariou, Serge Bovéda, et al.. (2024). Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality. PLoS ONE. 19(4). e0301753–e0301753. 5 indexed citations
2.
Lairez, Olivier, et al.. (2024). Towards etiological treatments in cardiomyopathies. La Presse Médicale. 53(1). 104223–104223. 1 indexed citations
3.
Colombat, Magali, Pauline Fournier, Bertrand Marcheix, et al.. (2024). Descriptive study of the clinical and myocardial status of a population with anatomopathological aortic valve amyloidosis. Cardiovascular Pathology. 73. 107674–107674. 1 indexed citations
4.
Cariou, Eve, Pauline Fournier, Yoan Lavie‐Badie, et al.. (2024). Prevalence, clinical significance and prognosis value of liver stiffness measurement anomalies in transthyretin cardiac amyloidosis. International Journal of Cardiology. 416. 132485–132485. 2 indexed citations
5.
Yun, Sergi, Giovanni Palladini, Lisa Anderson, et al.. (2024). International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction. Amyloid. 31(4). 291–301. 5 indexed citations
6.
Cariou, Eve, et al.. (2023). Development and validation of machine learning algorithms to predict posthypertensive origin in left ventricular hypertrophy. Archives of cardiovascular diseases. 116(8-9). 397–402. 6 indexed citations
7.
Sourdet, Sandrine, Eve Cariou, Pauline Fournier, et al.. (2023). Frailty in Older Patients with Transthyretin Cardiac Amyloidosis. Journal of Clinical Medicine. 12(24). 7507–7507. 2 indexed citations
8.
Cariou, Eve, Antoine Deney, Pauline Fournier, et al.. (2021). Sports participation and myocarditis: Influence of sport types on disease severity. IJC Heart & Vasculature. 37. 100895–100895. 4 indexed citations
9.
Cariou, Eve, Pauline Fournier, Antoine Huart, et al.. (2021). New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact. Frontiers in Cardiovascular Medicine. 8. 742428–742428. 18 indexed citations
10.
Maury, Philippe, Anne Rollin, Pierre Mondoly, et al.. (2021). Phase analysis for ventricular arrhythmia prediction: A retrospective monocentric cohort study. Journal of Nuclear Cardiology. 29(6). 3086–3098. 2 indexed citations
11.
12.
Fournier, Pauline, Eve Cariou, Antoine Huart, et al.. (2020). Gateway and Journey of Patients with Cardiac Amyloidosis. ESC Heart Failure. 7(5). 2418–2430. 15 indexed citations
13.
Lavie‐Badie, Yoan, Pauline Fournier, Michel Galinier, et al.. (2020). Impact of Tricuspid Regurgitation on Survival in Patients with Cardiac Amyloidosis. ESC Heart Failure. 8(1). 438–446. 13 indexed citations
14.
Lairez, Olivier, Fanny Vardon‐Bounes, Eve Cariou, et al.. (2020). Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study. International journal of cardiac imaging. 37(2). 449–457. 13 indexed citations
15.
Brun, S., David Ribes, Eve Cariou, et al.. (2019). Cardiac magnetic resonance imaging with late gadolinium enhancement in acute myocarditis: Towards differentiation between immune-mediated and viral-related aetiologies. Archives of cardiovascular diseases. 112(10). 559–566. 6 indexed citations
16.
Coisne, Augustin, Julien Dreyfus, Yohann Bohbot, et al.. (2018). Transoesophageal echocardiography current practice in France: A multicentre study. Archives of cardiovascular diseases. 111(12). 730–738. 3 indexed citations
17.
Brun, S., Eve Cariou, Pauline Fournier, et al.. (2018). Value of natriuretic peptides and tissue doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis. Archives of Cardiovascular Diseases Supplements. 11(1). 32–32. 1 indexed citations
18.
Galinier, Michel, Eve Cariou, Olivier Lairez, et al.. (2018). Place des peptides natriurétiques de type B dans le diagnostic précoce de l’insuffisance cardiaque en médecine de ville. La Presse Médicale. 47(9). 804–810. 1 indexed citations
19.
20.
Cariou, Eve, Pauline Fournier, David Ribes, et al.. (2017). 1962Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis. European Heart Journal. 38(suppl_1).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Pagura Breakdown of academic impact, for papers by J. Rahman Breakdown of academic impact, for papers by Sneha Vakamudi Breakdown of academic impact, for papers by Martin Nicol Breakdown of academic impact, for papers by Ghormallah B. Al-Zahrani Breakdown of academic impact, for papers by Biju Paul Breakdown of academic impact, for papers by Philipp Daniel Gaudron Breakdown of academic impact, for papers by Annabelle Nguyen Breakdown of academic impact, for papers by Vasvi Singh Breakdown of academic impact, for papers by Laura Krapf
Rankless by CCL
2026